Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Histone deacetylase 3 (HDAC 3) as emerging drug target in NF-κB-mediated inflammation
Niek G.J. Leus, Martijn R. H. Zwinderman, Frank J. Dekker
Current Opinion in Chemical Biology (2016) Vol. 33, pp. 160-168
Open Access | Times Cited: 124

Showing 1-25 of 124 citing articles:

Mechanisms of NF-κB p65 and strategies for therapeutic manipulation
Sivagami Giridharan, Mythily Srinivasan
Journal of Inflammation Research (2018) Vol. Volume 11, pp. 407-419
Open Access | Times Cited: 506
Valproic acid attenuates traumatic spinal cord injury-induced inflammation via STAT1 and NF-κB pathway dependent of HDAC3
Shoubo Chen, Jingfang Ye, Xiangrong Chen, et al.
Journal of Neuroinflammation (2018) Vol. 15, Iss. 1
Open Access | Times Cited: 246
The Anti-inflammatory Effects of Short Chain Fatty Acids on Lipopolysaccharide- or Tumor Necrosis Factor α-Stimulated Endothelial Cells via Activation of GPR41/43 and Inhibition of HDACs
Meng Li, Betty C. A. M. van Esch, Paul A. J. Henricks, et al.
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 245
The N6-methyladenosine (m6A)-forming enzyme METTL3 facilitates M1 macrophage polarization through the methylation of STAT1 mRNA
Yihan Liu, Zhujiang Liu, Hao Tang, et al.
AJP Cell Physiology (2019) Vol. 317, Iss. 4, pp. C762-C775
Closed Access | Times Cited: 211
Omega-3 polyunsaturated fatty acid attenuates the inflammatory response by modulating microglia polarization through SIRT1-mediated deacetylation of the HMGB1/NF-κB pathway following experimental traumatic brain injury
Xiangrong Chen, Chunnuan Chen, Sining Fan, et al.
Journal of Neuroinflammation (2018) Vol. 15, Iss. 1
Open Access | Times Cited: 210
RETRACTED: Inhibition of HDAC3 reverses Alzheimer’s disease-related pathologies in vitro and in the 3xTg-AD mouse model
Karolina J. Janczura, Claude‐Henry Volmar, Gregory C. Sartor, et al.
Proceedings of the National Academy of Sciences (2018) Vol. 115, Iss. 47
Open Access | Times Cited: 176
HDAC inhibitors: Targets for tumor therapy, immune modulation and lung diseases
Geetha Shanmugam, Sudeshna Rakshit, Koustav Sarkar
Translational Oncology (2021) Vol. 16, pp. 101312-101312
Open Access | Times Cited: 106
Inhibition of inflammatory microglia by dietary fiber and short-chain fatty acids
Maria Elisa Caetano‐Silva, Laurie A. Rund, Noah T. Hutchinson, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 88
Pharmacophore-based virtual screening, 3D QSAR, Docking, ADMET, and MD simulation studies: An in silico perspective for the identification of new potential HDAC3 inhibitors
Goverdhan Lanka, Darakhshan Begum, Suvankar Banerjee, et al.
Computers in Biology and Medicine (2023) Vol. 166, pp. 107481-107481
Closed Access | Times Cited: 58
Maternal High Fat Diet-Induced Obesity Modifies Histone Binding and Expression of Oxtr in Offspring Hippocampus in a Sex-Specific Manner
Kelly A. Glendining, Christine L. Jasoni
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 2, pp. 329-329
Open Access | Times Cited: 121
Epigenetic Mechanisms in Monocytes/Macrophages Regulate Inflammation in Cardiometabolic and Vascular Disease
Frank M. Davis, Katherine Gallagher
Arteriosclerosis Thrombosis and Vascular Biology (2019) Vol. 39, Iss. 4, pp. 623-634
Open Access | Times Cited: 119
Butyrate ameliorates caerulein‐induced acute pancreatitis and associated intestinal injury by tissue‐specific mechanisms
Xiaohua Pan, Xin Fang, Fei Wang, et al.
British Journal of Pharmacology (2019) Vol. 176, Iss. 23, pp. 4446-4461
Open Access | Times Cited: 113
Roles of Histone Deacetylases and Inhibitors in Anticancer Therapy
Flávia Alves Verza, Umashankar Das, Ana Lúcia Fachin, et al.
Cancers (2020) Vol. 12, Iss. 6, pp. 1664-1664
Open Access | Times Cited: 104
Development of Allosteric Hydrazide-Containing Class I Histone Deacetylase Inhibitors for Use in Acute Myeloid Leukemia
Jesse J. McClure, Cheng Zhang, Elizabeth S. Inks, et al.
Journal of Medicinal Chemistry (2016) Vol. 59, Iss. 21, pp. 9942-9959
Open Access | Times Cited: 90
HDAC inhibitors: A new promising drug class in anti-aging research
E. G. Pasyukova, Alexander Vaiserman
Mechanisms of Ageing and Development (2017) Vol. 166, pp. 6-15
Closed Access | Times Cited: 90
The molecular activity of cannabidiol in the regulation of Nrf2 system interacting with NF-κB pathway under oxidative stress
Sinemyiz Atalay, Agnieszka Gęgotek, Elżbieta Skrzydlewska
Redox Biology (2022) Vol. 57, pp. 102489-102489
Open Access | Times Cited: 54
Butyrate limits inflammatory macrophage niche in NASH
Ankita Sarkar, Priya Mitra, Abhishake Lahiri, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 5
Open Access | Times Cited: 36
Intestinal epithelial HDAC3 and MHC class II coordinate microbiota-specific immunity
Emily M. Eshleman, Tzu‐Yu Shao, Vivienne Woo, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 4
Open Access | Times Cited: 34
Epigenetic perspectives associated with COVID-19 infection and related cytokine storm: an updated review
Amit Dey, K. Vaishak, Dikshita Deka, et al.
Infection (2023) Vol. 51, Iss. 6, pp. 1603-1618
Open Access | Times Cited: 24
Targeted protein degradation: advances in drug discovery and clinical practice
Guangcai Zhong, Xiaoyu Chang, Weilin Xie, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 14
A phenotypic screening platform for identifying chemical modulators of astrocyte reactivity
Benjamin L.L. Clayton, James D. Kristell, Kevin Allan, et al.
Nature Neuroscience (2024) Vol. 27, Iss. 4, pp. 656-665
Open Access | Times Cited: 12
Exploring the role of histone deacetylase and histone deacetylase inhibitors in the context of multiple myeloma: mechanisms, therapeutic implications, and future perspectives
Jingjing Pu, Ting Liu, Xuzhen Wang, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 11
Design and Synthesis of Dual-Targeting Inhibitors of sEH and HDAC6 for the Treatment of Neuropathic Pain and Lipopolysaccharide-Induced Mortality
Yuanguang Chen, Jian‐Wen Sun, Hua Tong, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 3, pp. 2095-2117
Closed Access | Times Cited: 8
HDAC1-3 inhibitor MS-275 enhances IL10 expression in RAW264.7 macrophages and reduces cigarette smoke-induced airway inflammation in mice
Niek G.J. Leus, Thea van den Bosch, Petra E. van der Wouden, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 70
Induced protein degradation of histone deacetylases 3 (HDAC3) by proteolysis targeting chimera (PROTAC)
Fangyuan Cao, Sander de Weerd, Deng Chen, et al.
European Journal of Medicinal Chemistry (2020) Vol. 208, pp. 112800-112800
Open Access | Times Cited: 63
Page 1 - Next Page

Scroll to top